Earth Footwear of Waltham, Mass., is extending its brand franchise this spring with a series of career and dress looks under the Earthies label. Designed to appeal to the Earthies consumer’s more sophisticated side, the collection keeps the brand’s health and wellness DNA intact, with cushioned footbeds that cradle the foot to prevent slippage. “It’s the same customer, just a different part of her wardrobe,” said Julie Wellman, Earthies’ director of sales. Set to hit stores in January, the line retails for $119 to $159, with distribution targeted at department stores and independents.
Wayne, N.J.-based wellness brand Cogent is going more fashion-forward this spring with an updated collection designed to bring younger customers into the fold. Under the design direction of Maggi Mercado, the line will include more comfort-driven materials, such as neoprene, for a series of citrus-colored sandals and casuals for women and earth-toned sandals for men. In addition, tailored and athletic-inspired styles, all built on the brand’s proprietary double rocker bottom, will be part of the offering, retailing from $135 to $195.
MSZone Ltd., a South Korea-based wellness brand, is setting its sights on the U.S. market with the introduction of a collection of men’s and women’s styles, distributed by Human Motion in Evergreen, Colo. The shoes are based on the company’s signature Sensory Gait Line technology, designed to guide the user through the proper gait cycle. Stated benefits include the elimination of pronation. The line features a series of casuals, dress-casuals and sandals, all with lower-profile rocker bottoms, and sport styles on athletic-inspired rocker outsoles. Currently sold in Europe and Asia, the line is set to launch in U.S. stores in November. Retail prices range from $225 to $255, with distribution focused on comfort independents and the practitioner channel, which includes podiatrists, chiropractors and physical therapists. According to Bruce Anderson, president and CEO of Human Motion, MSZone has been approved as an FDA Class 1 medical device, which is based on a code ensuring safety and effectiveness.